{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:13:44Z","timestamp":1777054424544,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007069","name":"Universit\u00e0 della Calabria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007069","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Data concerning the number of diagnoses and of the drugs prescribed to patients affected by dementia are still scarce. Here we test whether or not (1) prescription of symptomatic drugs against Alzheimer\u2019s disease (AD) may approximate the number of patients affected by dementia in Italy and (2) adherence to this treatment affects the pattern of prescription of drugs (i.e. antipsychotics and antidepressants) for behavioural and psychological symptoms of dementia (BPSD) and the previously reported limited prescription of analgesics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective observational study concerns 84,235 subjects older than 60 years and registered in the provincial prescription database of the health district of Cosenza accounting for a population of 298,000 inhabitants. The prescribing pattern of antipsychotics, antidepressants, and analgesics has been investigated in patients receiving concurrent prescriptions of acetylcholinesterase inhibitors (AChEI) and\/or memantine. Data from a single centre for cognitive disturbances and dementia (CDCD) in the same health district were used to explore at which stage dementia was diagnosed. The study was approved by Calabria Region Ethical Committee no. 31\/2017 and registered on October 31, 2017.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The data show that 859 patients are treated with AChEI and\/or memantine; 420 patients (48.89%) receive at least 80% of the recommended medications. CDCD data indicate a delay in dementia diagnosis, which often was made when the patients were moderately to severely demented (Mini Mental State Examination, MMSE \u2264 20). Adherence did not influence prescription of most of the drugs explored, but use of non-steroidal anti-inflammatory drugs was higher in non-adherent patients. Antipsychotics and antidepressants are frequently used (20.61\u201320.71% and 42.37\u201351.43%, respectively), and this, at least in part, might stem from the observed under-treatment of chronic pain (opioids are prescribed in the 4.76% and 12.46% of adherent and non-adherent patients and gabapentin and pregabalin are used in the 4.29% and 4.07% of adherent and non-adherent patients respectively), resulting in more frequent BPSD. 16.43% of patients receive antipsychotics for longer than 6\u201312 weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This 2-year period study, including a wide cohort of community demented patients, shows that dementia is diagnosed late and that prevalence of BPSD prescriptions is high and not impacted by adherence to anti-dementia drugs. The rate of prescription of potentially harmful antipsychotics and antidepressants appears to be high though whether the concomitantly observed limited prescription of analgesics might be a contributing factor needs to be further investigated. Our data support the development of strategies to improve the management of BPSD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00228-020-02995-w","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T21:02:33Z","timestamp":1600203753000},"page":"241-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5846-7058","authenticated-orcid":false,"given":"Damiana","family":"Scuteri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maril\u00f9","family":"Vulnera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brunella","family":"Piro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Bruno","family":"Bossio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-8490","authenticated-orcid":false,"given":"Luigi Antonio","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6234-6777","authenticated-orcid":false,"given":"Giorgio","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-2187","authenticated-orcid":false,"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4867-1378","authenticated-orcid":false,"given":"Paolo","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-6218","authenticated-orcid":false,"given":"Giacinto","family":"Bagetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-0697","authenticated-orcid":false,"given":"Maria Tiziana","family":"Corasaniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"2995_CR1","volume-title":"World Alzheimer Report 2018. The state of the art of dementia research: new frontiers","author":"C Patterson","year":"2018","unstructured":"Patterson C (2018) World Alzheimer Report 2018. The state of the art of dementia research: new frontiers. Alzheimer\u2019s Disease International (ADI), London"},{"key":"2995_CR2","doi-asserted-by":"publisher","first-page":"9416305","DOI":"10.1155\/2017\/9416305","volume":"2017","author":"D Scuteri","year":"2017","unstructured":"Scuteri D, Morrone LA, Rombola L, Avato PR, Bilia AR, Corasaniti MT, Sakurada S, Sakurada T, Bagetta G (2017) Aromatherapy and aromatic plants for the treatment of behavioural and psychological symptoms of dementia in patients with Alzheimer\u2019s disease: clinical evidence and possible mechanisms. Evidence-Based Complement Altern Med eCAM 2017:9416305\u20139416308. https:\/\/doi.org\/10.1155\/2017\/9416305","journal-title":"Evidence-Based Complement Altern Med eCAM"},{"issue":"20","key":"2995_CR3","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.2174\/0929867325666180307115546","volume":"26","author":"D Scuteri","year":"2019","unstructured":"Scuteri D, Rombola L, Tridico L, Mizoguchi H, Watanabe C, Sakurada T, Sakurada S, Corasaniti MT, Bagetta G, Morrone LA (2019) Neuropharmacological properties of the essential oil of bergamot for the clinical management of pain-related BPSDs. Curr Med Chem 26(20):3764\u20133774. https:\/\/doi.org\/10.2174\/0929867325666180307115546","journal-title":"Curr Med Chem"},{"issue":"4","key":"2995_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/gps.1302","volume":"20","author":"MJ Vernooij-Dassen","year":"2005","unstructured":"Vernooij-Dassen MJ, Moniz-Cook ED, Woods RT, De Lepeleire J, Leuschner A, Zanetti O, de Rotrou J, Kenny G, Franco M, Peters V, Iliffe S (2005) Factors affecting timely recognition and diagnosis of dementia across Europe: from awareness to stigma. Int J Geriatric Psych 20(4):377\u2013386. https:\/\/doi.org\/10.1002\/gps.1302","journal-title":"Int J Geriatric Psych"},{"issue":"4","key":"2995_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/13607863.2015.1015962","volume":"20","author":"D Gove","year":"2016","unstructured":"Gove D, Downs M, Vernooij-Dassen M, Small N (2016) Stigma and GPs\u2019 perceptions of dementia. Aging Ment Health 20(4):391\u2013400. https:\/\/doi.org\/10.1080\/13607863.2015.1015962","journal-title":"Aging Ment Health"},{"issue":"5","key":"2995_CR6","first-page":"457","volume":"60","author":"J Parmar","year":"2014","unstructured":"Parmar J, Dobbs B, McKay R, Kirwan C, Cooper T, Marin A, Gupta N (2014) Diagnosis and management of dementia in primary care: exploratory study. Canadian family physician Medecin de famille canadien 60(5):457\u2013465","journal-title":"Canadian family physician Medecin de famille canadien"},{"issue":"19","key":"2995_CR7","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1001\/archinte.160.19.2964","volume":"160","author":"VG Valcour","year":"2000","unstructured":"Valcour VG, Masaki KH, Curb JD, Blanchette PL (2000) The detection of dementia in the primary care setting. Arch Intern Med 160(19):2964\u20132968. https:\/\/doi.org\/10.1001\/archinte.160.19.2964","journal-title":"Arch Intern Med"},{"issue":"3","key":"2995_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/0706743716673321","volume":"62","author":"J Kirkham","year":"2017","unstructured":"Kirkham J, Sherman C, Velkers C, Maxwell C, Gill S, Rochon P, Seitz D (2017) Antipsychotic use in dementia. Can J Psychiatr 62(3):170\u2013181. https:\/\/doi.org\/10.1177\/0706743716673321","journal-title":"Can J Psychiatr"},{"issue":"2","key":"2995_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/gps.1858","volume":"23","author":"M Steinberg","year":"2008","unstructured":"Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, Breitner JC, Steffens DC, Tschanz JT, Cache County I (2008) Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatric Psych 23(2):170\u2013177. https:\/\/doi.org\/10.1002\/gps.1858","journal-title":"Int J Geriatric Psych"},{"key":"2995_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.dadm.2019.02.006","volume":"11","author":"EA Wise","year":"2019","unstructured":"Wise EA, Rosenberg PB, Lyketsos CG, Leoutsakos JM (2019) Time course of neuropsychiatric symptoms and cognitive diagnosis in National Alzheimer\u2019s Coordinating Centers volunteers. Alzheimers Dement (Amst) 11:333\u2013339. https:\/\/doi.org\/10.1016\/j.dadm.2019.02.006","journal-title":"Alzheimers Dement (Amst)"},{"issue":"10","key":"2995_CR11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/gps.4933","volume":"33","author":"AO Vik-Mo","year":"2018","unstructured":"Vik-Mo AO, Giil LM, Ballard C, Aarsland D (2018) Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study. Int J Geriatric Psych 33(10):1361\u20131369. https:\/\/doi.org\/10.1002\/gps.4933","journal-title":"Int J Geriatric Psych"},{"key":"2995_CR12","doi-asserted-by":"publisher","unstructured":"Scuteri D, Rombola L, Morrone LA, Bagetta G, Sakurada S, Sakurada T, Tonin P, Corasaniti MT (2019) Neuropharmacology of the neuropsychiatric symptoms of dementia and role of pain: essential oil of bergamot as a novel therapeutic approach. Int J Mol Sci 20(13). https:\/\/doi.org\/10.3390\/ijms20133327","DOI":"10.3390\/ijms20133327"},{"issue":"5","key":"2995_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrneurol.2009.39","volume":"5","author":"CG Ballard","year":"2009","unstructured":"Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG (2009) Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 5(5):245\u2013255. https:\/\/doi.org\/10.1038\/nrneurol.2009.39","journal-title":"Nat Rev Neurol"},{"issue":"15","key":"2995_CR14","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","volume":"294","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, Dagerman KS, Insel P (2005) Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Jama 294(15):1934\u20131943. https:\/\/doi.org\/10.1001\/jama.294.15.1934","journal-title":"Jama"},{"issue":"6","key":"2995_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ageing\/afr105","volume":"40","author":"R Duncan","year":"2011","unstructured":"Duncan R, Francis RM, Collerton J, Davies K, Jagger C, Kingston A, Kirkwood T, Robinson L, Birrell F (2011) Prevalence of arthritis and joint pain in the oldest old: findings from the Newcastle 85+ study. Age Ageing 40(6):752\u2013755. https:\/\/doi.org\/10.1093\/ageing\/afr105","journal-title":"Age Ageing"},{"issue":"5","key":"2995_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2217\/pmt-2019-0023","volume":"9","author":"WP Achterberg","year":"2019","unstructured":"Achterberg WP (2019) How can the quality of life of older patients living with chronic pain be improved? Pain Manag 9(5):431\u2013433. https:\/\/doi.org\/10.2217\/pmt-2019-0023","journal-title":"Pain Manag"},{"key":"2995_CR17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2147\/CIA.S36739","volume":"8","author":"WP Achterberg","year":"2013","unstructured":"Achterberg WP, Pieper MJ, van Dalen-Kok AH, de Waal MW, Husebo BS, Lautenbacher S, Kunz M, Scherder EJ, Corbett A (2013) Pain management in patients with dementia. Clin Interv Aging 8:1471\u20131482. https:\/\/doi.org\/10.2147\/CIA.S36739","journal-title":"Clin Interv Aging"},{"issue":"4","key":"2995_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/j.pain.0000000000000095","volume":"156","author":"EL Sampson","year":"2015","unstructured":"Sampson EL, White N, Lord K, Leurent B, Vickerstaff V, Scott S, Jones L (2015) Pain, agitation, and behavioural problems in people with dementia admitted to general hospital wards: a longitudinal cohort study. Pain 156(4):675\u2013683. https:\/\/doi.org\/10.1097\/j.pain.0000000000000095","journal-title":"Pain"},{"key":"2995_CR19","doi-asserted-by":"publisher","first-page":"d4065","DOI":"10.1136\/bmj.d4065","volume":"343","author":"BS Husebo","year":"2011","unstructured":"Husebo BS, Ballard C, Sandvik R, Nilsen OB, Aarsland D (2011) Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. Bmj 343:d4065. https:\/\/doi.org\/10.1136\/bmj.d4065","journal-title":"Bmj"},{"key":"2995_CR20","doi-asserted-by":"publisher","first-page":"504691","DOI":"10.1155\/2015\/504691","volume":"2015","author":"L Doan","year":"2015","unstructured":"Doan L, Manders T, Wang J (2015) Neuroplasticity underlying the comorbidity of pain and depression. Neural Plastic 2015:504691\u2013504616. https:\/\/doi.org\/10.1155\/2015\/504691","journal-title":"Neural Plastic"},{"issue":"8","key":"2995_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/jamainternmed.2017.1622","volume":"177","author":"EL Whitlock","year":"2017","unstructured":"Whitlock EL, Diaz-Ramirez LG, Glymour MM, Boscardin WJ, Covinsky KE, Smith AK (2017) Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. JAMA Intern Med 177(8):1146\u20131153. https:\/\/doi.org\/10.1001\/jamainternmed.2017.1622","journal-title":"JAMA Intern Med"},{"issue":"2","key":"2995_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/1567205016666181212162424","volume":"16","author":"A Ezzati","year":"2019","unstructured":"Ezzati A, Wang C, Katz MJ, Derby CA, Zammit AR, Zimmerman ME, Pavlovic JM, Sliwinski MJ, Lipton RB (2019) The temporal relationship between pain intensity and pain interference and incident dementia. Curr Alzheimer Res 16(2):109\u2013115. https:\/\/doi.org\/10.2174\/1567205016666181212162424","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"2995_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.11138\/fneur\/2017.32.4.229","volume":"22","author":"D Scuteri","year":"2017","unstructured":"Scuteri D, Piro B, Morrone LA, Corasaniti MT, Vulnera M, Bagetta G (2017) The need for better access to pain treatment: learning from drug consumption trends in the USA. Funct Neurol 22(4):229\u2013230. https:\/\/doi.org\/10.11138\/fneur\/2017.32.4.229","journal-title":"Funct Neurol"},{"issue":"9","key":"2995_CR24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.4103\/1673-5374.237125","volume":"13","author":"D Scuteri","year":"2018","unstructured":"Scuteri D, Garreffa MR, Esposito S, Bagetta G, Naturale MD, Corasaniti MT (2018) Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy. Neural Regen Res 13(9):1619\u20131621. https:\/\/doi.org\/10.4103\/1673-5374.237125","journal-title":"Neural Regen Res"},{"issue":"1","key":"2995_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"GBDD Collaborators","year":"2019","unstructured":"Collaborators GBDD (2019) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(1):88\u2013106. https:\/\/doi.org\/10.1016\/S1474-4422(18)30403-4","journal-title":"Lancet Neurol"},{"issue":"2","key":"2995_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3233\/JAD-190030","volume":"69","author":"JK Zakarias","year":"2019","unstructured":"Zakarias JK, Jensen-Dahm C, Norgaard A, Roos P, Gasse C, Phung TKT, Waldemar G (2019) Geographical variation in the diagnostic rate and quality of dementia diagnoses. J Alzheimer's Dis JAD 69(2):513\u2013520. https:\/\/doi.org\/10.3233\/JAD-190030","journal-title":"J Alzheimer's Dis JAD"},{"key":"2995_CR27","unstructured":"https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/262139\/Dementia.pdf DoHU (.)."},{"issue":"7","key":"2995_CR28","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s11606-018-4377-y","volume":"33","author":"H Amjad","year":"2018","unstructured":"Amjad H, Roth DL, Sheehan OC, Lyketsos CG, Wolff JL, Samus QM (2018) Underdiagnosis of dementia: an observational study of patterns in diagnosis and awareness in US older adults. J Gen Intern Med 33(7):1131\u20131138. https:\/\/doi.org\/10.1007\/s11606-018-4377-y","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2995_CR29","doi-asserted-by":"publisher","first-page":"e011146","DOI":"10.1136\/bmjopen-2016-011146","volume":"7","author":"L Lang","year":"2017","unstructured":"Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G, Danat IM, Zhou W, Copeland JR, Anstey KJ, Chen R (2017) Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open 7(2):e011146. https:\/\/doi.org\/10.1136\/bmjopen-2016-011146","journal-title":"BMJ Open"},{"key":"2995_CR30","unstructured":"https:\/\/www.epicentro.iss.it\/alzheimer\/world-alzheimer-day-2019. NIoHI (.)."},{"issue":"3","key":"2995_CR31","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S2468-2667(17)30031-2","volume":"2","author":"K Donegan","year":"2017","unstructured":"Donegan K, Fox N, Black N, Livingston G, Banerjee S, Burns A (2017) Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study. Lancet Public Health 2(3):e149\u2013e156. https:\/\/doi.org\/10.1016\/S2468-2667(17)30031-2","journal-title":"Lancet Public Health"},{"issue":"1","key":"2995_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-018-0379-6","volume":"10","author":"VM Walker","year":"2018","unstructured":"Walker VM, Davies NM, Kehoe PG, Martin RM (2018) What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink. Alzheimers Res Ther 10(1):51. https:\/\/doi.org\/10.1186\/s13195-018-0379-6","journal-title":"Alzheimers Res Ther"},{"key":"2995_CR33","volume-title":"WHO Adherence Meeting Report","author":"E Sabate","year":"2001","unstructured":"Sabate E (2001) WHO Adherence Meeting Report. World Health Organization, Geneva"},{"issue":"2","key":"2995_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0091217416636601","volume":"51","author":"SV Phan","year":"2016","unstructured":"Phan SV (2016) Medication adherence in patients with schizophrenia. Int J Psychiatry Med 51(2):211\u2013219. https:\/\/doi.org\/10.1177\/0091217416636601","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"2995_CR35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1183\/09031936.00075614","volume":"45","author":"M Engelkes","year":"2015","unstructured":"Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC, Verhamme KM (2015) Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J 45(2):396\u2013407. https:\/\/doi.org\/10.1183\/09031936.00075614","journal-title":"Eur Respir J"},{"issue":"2","key":"2995_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaip.2016.09.022","volume":"5","author":"PC Souverein","year":"2017","unstructured":"Souverein PC, Koster ES, Colice G, van Ganse E, Chisholm A, Price D, Dima AL, Respiratory Effectiveness Group\u2019s Adherence Working G (2017) Inhaled corticosteroid adherence patterns in a longitudinal asthma cohort. J Allergy Clin Immunol Pract 5(2):448\u2013456 e442. https:\/\/doi.org\/10.1016\/j.jaip.2016.09.022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"2995_CR37","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.jaip.2018.03.008","volume":"6","author":"A Papi","year":"2018","unstructured":"Papi A, Ryan D, Soriano JB, Chrystyn H, Bjermer L, Rodriguez-Roisin R, Dolovich MB, Harris M, Wood L, Batsiou M, Thornhill SI, Price DB (2018) Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma. J Allergy Clin Immunol Pract 6(6):1989\u20131998 e1983. https:\/\/doi.org\/10.1016\/j.jaip.2018.03.008","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"2995_CR38","doi-asserted-by":"publisher","first-page":"00324","DOI":"10.1183\/23120541.00324-2019","volume":"6","author":"I Vahatalo","year":"2020","unstructured":"Vahatalo I, Ilmarinen P, Tuomisto LE, Tommola M, Niemela O, Lehtimaki L, Nieminen P, Kankaanranta H (2020) 12-year adherence to inhaled corticosteroids in adult-onset asthma. ERJ Open Res 6(1):00324\u201302019. https:\/\/doi.org\/10.1183\/23120541.00324-2019","journal-title":"ERJ Open Res"},{"issue":"4","key":"2995_CR39","doi-asserted-by":"publisher","first-page":"729","DOI":"10.12669\/pjms.36.4.1923","volume":"36","author":"M Algameel","year":"2020","unstructured":"Algameel M (2020) Patterns of medication use and adherence to medications among residents in the elderly homes. Pakistan J Medic Sci 36(4):729\u2013734. https:\/\/doi.org\/10.12669\/pjms.36.4.1923","journal-title":"Pakistan J Medic Sci"},{"issue":"3","key":"2995_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0897190017710524","volume":"31","author":"N El-Saifi","year":"2018","unstructured":"El-Saifi N, Moyle W, Jones C, Tuffaha H (2018) Medication adherence in older patients with dementia: a systematic literature review. J Pharm Pract 31(3):322\u2013334. https:\/\/doi.org\/10.1177\/0897190017710524","journal-title":"J Pharm Pract"},{"issue":"2","key":"2995_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40263-013-0133-3","volume":"28","author":"V Gardette","year":"2014","unstructured":"Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S, Group I (2014) A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer\u2019s disease in Europe : predictors of discontinuation and switch in the ICTUS study. CNS Drugs 28(2):157\u2013170. https:\/\/doi.org\/10.1007\/s40263-013-0133-3","journal-title":"CNS Drugs"},{"key":"2995_CR42","doi-asserted-by":"publisher","first-page":"CD003154","DOI":"10.1002\/14651858.CD003154.pub6","volume":"3","author":"R McShane","year":"2019","unstructured":"McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J (2019) Memantine for dementia. Cochrane Database Syst Rev 3:CD003154. https:\/\/doi.org\/10.1002\/14651858.CD003154.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"2995_CR43","doi-asserted-by":"publisher","first-page":"CD003154","DOI":"10.1002\/14651858.CD003154.pub5","volume":"2","author":"R McShane","year":"2006","unstructured":"McShane R, Areosa Sastre A, Minakaran N (2006) Memantine for dementia. Cochrane Database Syst Rev 2:CD003154. https:\/\/doi.org\/10.1002\/14651858.CD003154.pub5","journal-title":"Cochrane Database Syst Rev"},{"issue":"1-2","key":"2995_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2013.10.015","volume":"336","author":"FF de Oliveira","year":"2014","unstructured":"de Oliveira FF, Bertolucci PH, Chen ES, Smith Mde A (2014) Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer\u2019s disease. J Neurol Sci 336(1-2):103\u2013108. https:\/\/doi.org\/10.1016\/j.jns.2013.10.015","journal-title":"J Neurol Sci"},{"issue":"11","key":"2995_CR45","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2165\/11584290-000000000-00000","volume":"27","author":"DW Scharre","year":"2010","unstructured":"Scharre DW, Vekeman F, Lefebvre P, Mody-Patel N, Kahler KH, Duh MS (2010) Use of antipsychotic drugs in patients with Alzheimer\u2019s disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study. Drugs Aging 27(11):903\u2013913. https:\/\/doi.org\/10.2165\/11584290-000000000-00000","journal-title":"Drugs Aging"},{"issue":"1","key":"2995_CR46","doi-asserted-by":"publisher","first-page":"e002080","DOI":"10.1136\/bmjopen-2012-002080","volume":"3","author":"C Martinez","year":"2013","unstructured":"Martinez C, Jones RW, Rietbrock S (2013) Trends in the prevalence of antipsychotic drug use among patients with Alzheimer\u2019s disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open 3(1):e002080. https:\/\/doi.org\/10.1136\/bmjopen-2012-002080","journal-title":"BMJ Open"},{"issue":"4","key":"2995_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/070674371305800404","volume":"58","author":"J Lachaine","year":"2013","unstructured":"Lachaine J, Beauchemin C, Crochard A, Bineau S (2013) The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Regie de l\u2019Assurance Maladie du Quebec database. Can J Psychiatr 58(4):195\u2013200. https:\/\/doi.org\/10.1177\/070674371305800404","journal-title":"Can J Psychiatr"},{"issue":"3","key":"2995_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4088\/jcp.v69n0302","volume":"69","author":"GK Wilcock","year":"2008","unstructured":"Wilcock GK, Ballard CG, Cooper JA, Loft H (2008) Memantine for agitation\/aggression and psychosis in moderately severe to severe Alzheimer\u2019s disease: a pooled analysis of 3 studies. J Clin Psychol 69(3):341\u2013348. https:\/\/doi.org\/10.4088\/jcp.v69n0302","journal-title":"J Clin Psychol"},{"issue":"5","key":"2995_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/gps.1949","volume":"23","author":"S Gauthier","year":"2008","unstructured":"Gauthier S, Loft H, Cummings J (2008) Improvement in behavioural symptoms in patients with moderate to severe Alzheimer\u2019s disease by memantine: a pooled data analysis. Int J Geriatric Psych 23(5):537\u2013545. https:\/\/doi.org\/10.1002\/gps.1949","journal-title":"Int J Geriatric Psych"},{"issue":"2","key":"2995_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40266-016-0434-6","volume":"34","author":"AH Ford","year":"2017","unstructured":"Ford AH, Almeida OP (2017) Management of depression in patients with dementia: is pharmacological treatment justified? Drugs Aging 34(2):89\u201395. https:\/\/doi.org\/10.1007\/s40266-016-0434-6","journal-title":"Drugs Aging"},{"issue":"18","key":"2995_CR51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3238\/arztebl.2010.0320","volume":"107","author":"T Majic","year":"2010","unstructured":"Majic T, Pluta JP, Mell T, Aichberger MC, Treusch Y, Gutzmann H, Heinz A, Rapp MA (2010) The pharmacotherapy of neuropsychiatric symptoms of dementia: a cross-sectional study in 18 homes for the elderly in Berlin. Deutsches Arzteblatt Int 107(18):320\u2013327. https:\/\/doi.org\/10.3238\/arztebl.2010.0320","journal-title":"Deutsches Arzteblatt Int"},{"issue":"4","key":"2995_CR52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1017\/S1041610214002610","volume":"27","author":"CM Giebel","year":"2015","unstructured":"Giebel CM, Sutcliffe C, Renom-Guiteras A, Arve S, Hallberg IR, Soto M, Zabalegui A, Hamers J, Saks K, Challis D (2015) Depressive symptomatology in severe dementia in a European sample: prevalence, associated factors and prescription rate of antidepressants. Int Psychogeriatr 27(4):657\u2013667. https:\/\/doi.org\/10.1017\/S1041610214002610","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"2995_CR53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1017\/S1041610214002427","volume":"27","author":"ML Laitinen","year":"2015","unstructured":"Laitinen ML, Lonnroos E, Bell JS, Lavikainen P, Sulkava R, Hartikainen S (2015) Use of antidepressants among community-dwelling persons with Alzheimer\u2019s disease: a nationwide register-based study. Int Psychogeriatr 27(4):669\u2013672. https:\/\/doi.org\/10.1017\/S1041610214002427","journal-title":"Int Psychogeriatr"},{"issue":"7","key":"2995_CR54","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/gps.4517","volume":"32","author":"A Breining","year":"2017","unstructured":"Breining A, Bonnet-Zamponi D, Zerah L, Micheneau C, Riolacci-Dhoyen N, Chan-Chee C, Deligne J, Harlin JM, Boddaert J, Verny M, Leperre-Desplanques A (2017) Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study. Int J Geriatric Psych 32(7):750\u2013760. https:\/\/doi.org\/10.1002\/gps.4517","journal-title":"Int J Geriatric Psych"},{"key":"2995_CR55","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3389\/fphar.2019.00841","volume":"10","author":"P Hessmann","year":"2019","unstructured":"Hessmann P, Zeidler J, Stahmeyer J, Eberhard S, Vogelgsang J, Abdel-Hamid M, Wolff-Menzler C, Wiltfang J, Kis B (2019) Claims data analysis on the dispensing of tricyclic antidepressants among patients with dementia in Germany. Front Pharmacol 10:841. https:\/\/doi.org\/10.3389\/fphar.2019.00841","journal-title":"Front Pharmacol"},{"issue":"24","key":"2995_CR56","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"JE Malberg","year":"2000","unstructured":"Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20(24):9104\u20139110","journal-title":"J Neurosci"},{"issue":"11","key":"2995_CR57","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12272-013-0238-8","volume":"36","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kim W, Kong SY (2013) Antidepressants for neuro-regeneration: from depression to Alzheimer\u2019s disease. Arch Pharm Res 36(11):1279\u20131290. https:\/\/doi.org\/10.1007\/s12272-013-0238-8","journal-title":"Arch Pharm Res"},{"issue":"2","key":"2995_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/sj.clpt.6100035","volume":"81","author":"F Landi","year":"2007","unstructured":"Landi F, Russo A, Liperoti R, Cesari M, Barillaro C, Pahor M, Bernabei R, Onder G (2007) Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 81(2):235\u2013241. https:\/\/doi.org\/10.1038\/sj.clpt.6100035","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2995_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s40266-012-0044-x","volume":"30","author":"L Pasina","year":"2013","unstructured":"Pasina L, Djade CD, Lucca U, Nobili A, Tettamanti M, Franchi C, Salerno F, Corrao S, Marengoni A, Iorio A, Marcucci M, Violi F, Mannucci PM (2013) Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Drugs Aging 30(2):103\u2013112. https:\/\/doi.org\/10.1007\/s40266-012-0044-x","journal-title":"Drugs Aging"},{"issue":"11","key":"2995_CR60","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jamda.2014.08.002","volume":"15","author":"F Landi","year":"2014","unstructured":"Landi F, Dell'Aquila G, Collamati A, Martone AM, Zuliani G, Gasperini B, Eusebi P, Lattanzio F, Cherubini A (2014) Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc 15(11):825\u2013829. https:\/\/doi.org\/10.1016\/j.jamda.2014.08.002","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"2995_CR61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12603-016-0787-x","volume":"21","author":"V Boccardi","year":"2017","unstructured":"Boccardi V, Baroni M, Paolacci L, Ercolani S, Longo A, Giordano M, Ruggiero C, Mecocci P (2017) Anticholinergic burden and functional status in older people with cognitive impairment: results from the regal project. J Nutr Health Aging 21(4):389\u2013396. https:\/\/doi.org\/10.1007\/s12603-016-0787-x","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"2995_CR62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcp.12617","volume":"80","author":"K Ruxton","year":"2015","unstructured":"Ruxton K, Woodman RJ, Mangoni AA (2015) Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol 80(2):209\u2013220. https:\/\/doi.org\/10.1111\/bcp.12617","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2995_CR63","doi-asserted-by":"publisher","first-page":"e00310","DOI":"10.1002\/prp2.310","volume":"5","author":"A Egberts","year":"2017","unstructured":"Egberts A, van der Craats ST, van Wijk MD, Alkilabe S, van den Bemt P, Mattace-Raso FUS (2017) Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients. Pharmacol Res Perspect 5(3):e00310. https:\/\/doi.org\/10.1002\/prp2.310","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"2995_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40520-015-0359-7","volume":"28","author":"A Collamati","year":"2016","unstructured":"Collamati A, Martone AM, Poscia A, Brandi V, Celi M, Marzetti E, Cherubini A, Landi F (2016) Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res 28(1):25\u201335. https:\/\/doi.org\/10.1007\/s40520-015-0359-7","journal-title":"Aging Clin Exp Res"},{"issue":"10","key":"2995_CR65","doi-asserted-by":"publisher","first-page":"e0205897","DOI":"10.1371\/journal.pone.0205897","volume":"13","author":"LP De Vreese","year":"2018","unstructured":"De Vreese LP, Mantesso U, De Bastiani E, Marangoni A, Weger E, Gomiero T (2018) Anticholinergic burden in adult and elderly people with intellectual disabilities: results from an Italian multicenter cross-sectional study. PLoS ONE 13(10):e0205897. https:\/\/doi.org\/10.1371\/journal.pone.0205897","journal-title":"PLoS ONE"},{"issue":"7","key":"2995_CR66","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/gps.4384","volume":"31","author":"YM Choe","year":"2016","unstructured":"Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK, Byun MS, Bak JH, Lee JM, Yun HJ, Han MI, Woo JI, Lee DY (2016) Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer\u2019s disease. Int J Geriatric Psych 31(7):731\u2013739. https:\/\/doi.org\/10.1002\/gps.4384","journal-title":"Int J Geriatric Psych"},{"issue":"2","key":"2995_CR67","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3233\/JAD-160225","volume":"55","author":"H An","year":"2017","unstructured":"An H, Choi B, Park KW, Kim DH, Yang DW, Hong CH, Kim SY, Han SH (2017) The effect of escitalopram on mood and cognition in depressive Alzheimer\u2019s disease subjects. J Alzheimer's Dis JAD 55(2):727\u2013735. https:\/\/doi.org\/10.3233\/JAD-160225","journal-title":"J Alzheimer's Dis JAD"},{"issue":"2","key":"2995_CR68","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160828","volume":"56","author":"A Norgaard","year":"2017","unstructured":"Norgaard A, Jensen-Dahm C, Gasse C, Hansen ES, Waldemar G (2017) Psychotropic polypharmacy in patients with dementia: prevalence and predictors. J Alzheimer\u2019s Dis JAD 56(2):707\u2013716. https:\/\/doi.org\/10.3233\/JAD-160828","journal-title":"J Alzheimer\u2019s Dis JAD"},{"issue":"9","key":"2995_CR69","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x","volume":"18","author":"CS Zin","year":"2014","unstructured":"Zin CS, Chen LC, Knaggs RD (2014) Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain 18(9):1343\u20131351. https:\/\/doi.org\/10.1002\/j.1532-2149.2014.496.x","journal-title":"Eur J Pain"},{"issue":"7","key":"2995_CR70","first-page":"553","volume":"63","author":"CG Ballard","year":"2002","unstructured":"Ballard CG, O'Brien JT, Reichelt K, Perry EK (2002) Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychol 63(7):553\u2013558","journal-title":"J Clin Psychol"},{"key":"2995_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.fitote.2018.06.007","volume":"129","author":"D Scuteri","year":"2018","unstructured":"Scuteri D, Crudo M, Rombola L, Watanabe C, Mizoguchi H, Sakurada S, Sakurada T, Greco R, Corasaniti MT, Morrone LA, Bagetta G (2018) Antinociceptive effect of inhalation of the essential oil of bergamot in mice. Fitoterapia 129:20\u201324. https:\/\/doi.org\/10.1016\/j.fitote.2018.06.007","journal-title":"Fitoterapia"},{"issue":"6","key":"2995_CR72","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.fitote.2010.01.013","volume":"81","author":"G Bagetta","year":"2010","unstructured":"Bagetta G, Morrone LA, Rombola L, Amantea D, Russo R, Berliocchi L, Sakurada S, Sakurada T, Rotiroti D, Corasaniti MT (2010) Neuropharmacology of the essential oil of bergamot. Fitoterapia 81(6):453\u2013461. https:\/\/doi.org\/10.1016\/j.fitote.2010.01.013","journal-title":"Fitoterapia"},{"key":"2995_CR73","doi-asserted-by":"publisher","first-page":"2156873","DOI":"10.1155\/2019\/2156873","volume":"2019","author":"L Rombol\u00e0","year":"2019","unstructured":"Rombol\u00e0 L, Scuteri D, Adornetto A, Straface A, Sakurada T, Sakurada S, Mizoguchi H, Corasaniti MT, Bagetta G, Tonin P, Morrone LA (2019) Anxiolytic-like effects of bergamot essential oil are insensitive to flumazenil in rat. Evid Based Complement Alternat Med 2019:2156873\u20132156876. https:\/\/doi.org\/10.1155\/2019\/2156873","journal-title":"Evid Based Complement Alternat Med"},{"key":"2995_CR74","doi-asserted-by":"publisher","unstructured":"Rombola L, Tridico L, Scuteri D, Sakurada T, Sakurada S, Mizoguchi H, Avato P, Corasaniti MT, Bagetta G, Morrone LA (2017) Bergamot essential oil attenuates anxiety-like behaviour in rats. Molecules 22(4). https:\/\/doi.org\/10.3390\/molecules22040614","DOI":"10.3390\/molecules22040614"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-02995-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02995-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T02:37:16Z","timestamp":1631673436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-02995-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2995"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-02995-w","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved (no. 31\/2017) by the Ethics Committee, Section for Northern Calabria, Calabria Region, 87100, Cosenza, Italy, registered on October 31, 2017.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study was carried out using retrospectively collected and anonymized data. The need for written informed consent was waived owing to the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The study was carried out using retrospectively collected and anonymized data; therefore, the consent for publication was not needed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}